 Reduction defibrillator shocks implantable device antitachycardia pacing shock therapy Implantable defibrillators risk sudden death patients malignant ventricular arrhythmias significant restriction quality life result frequent device activation device pacing shock therapy frequency shocks implantation consecutive patients initial implantation defibrillator patients implanted device antitachycardia pacing shock therapy tachycardia characteristics results therapy device memory men women years mean Left ventricular ejection fraction mean patients episodes cardiac arrest Induced arrhythmias sustained monomorphic ventricular tachycardia patients nonsustained polymorphic ventricular tachycardia ventricular fibrillation total follow-up period patient-months patients spontaneous arrhythmic events patients episodes tachycardia antitachycardia pacing successful occasions Acceleration ventricular tachycardia therapy times Syncope pacing-induced acceleration ventricular tachycardia episodes tachycardia patients shocks short tachycardia cycle length tachycardias need shocks patients cardiorespiratory failure patient detected tachyarrhythmia